Yasuo Takamatsu

Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer

Yasuhiro Matsumura, Mitsukazu Gotoh, Kei Muro et al. · Annals of Oncology · 2004 · 253 citations

Medicine, Pharmacokinetics, Pharmacology +14

Phase I Clinical Study of MCI-186(Edaravone, 3-methyl-1-phenyl-2-pyrazolin-5-one) in Healthy Volunteers: Safety and Pharmacokinetics of Single and Multiple Administrations.

Hisao Shibata, Shigenori ARAI, Minae IZAWA et al. · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · 1998 · 38 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +11

A new sensitive determination method of estradiol in plasma using peroxyoxalate ester chemiluminescence combined with an HPLC system

Hiroyuki Yamada, Yasuhiro Kuwahara, Yasuo Takamatsu et al. · Biomedical Chromatography · 2000 · 22 citations

Natural Sciences, Chemistry, Analytical Chemistry +15

Pharmacokinetic Studies of 3-Methyl-1-phenyl-2-pyrazolin-5-one(MCI-186): Metabolism in Rats, Dogs and Human.

Teiko KOMATSU, Hiroshi Nakai, Yasuo Takamatsu et al. · Drug Metabolism and Pharmacokinetics · 1996 · 12 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +8

Inhibition of human hepatic glutathione S-transferase isozymes by ethacrynic acid and its metabolites

Yasuo Takamatsu, Inaba Tadanobu · Toxicology Letters · 1992 · 10 citations

Life Sciences, Biochemistry, Pharmacology +14